Latest Updates & News

FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023

FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023

What is Leqembi prescribed for?   Leqembi is prescribed to treat Alzheimer’s disease for people in the early stages of the disease. What is the name of the drug and what does it do?  The U.S. Food and Drug Administration has approved Leqembi (generic name: lecanemab-irmb), pronounced “leh-kem’-bee,” for the treatment of Alzheimer's disease. ...

FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024

FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024

What is Amtagvi prescribed for?   Amtagvi is prescribed to treat adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. What is the name of the drug and what does it do?  The newly approved drug is called Amtagvi...

FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023

FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023

What is BRENZAVVY prescribed for?   BRENZAVVY is prescribed to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise. What is the name of the drug and what does it do? BRENZAVVY, pronounced bren-ZA-vee, (generic name: bexagliflozin) , is used to improve blood sugar control in adults with type 2 diabetes. It...

FDA Approves Xolair for Food Allergy Management on February 16, 2024

FDA Approves Xolair for Food Allergy Management on February 16, 2024

What is Xolair prescribed for?   Xolair is prescribed to treat food allergy in people 1 year of age and older to reduce allergic reactions that may occur after accidentally eating one or more foods to which you are allergic. What is the name of the drug and what does it do? Xolair, pronounced ZOHL-air, (generic name: omalizumab), a medication previously...